Showing results (141-150 of 180) with videos related to
Sort By:
Pageof 18
Diseases of the Colon and Rectum|May 17, 2000
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomographyJ G Guillem, J Puig-La Calle, T Akhurst, et al.Journal of Hepatology|July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtideMaria Buti, Heiner Wedemeyer, Soo Aleman, et al.The New England Journal of Medicine|June 3, 2011
Detection of blast-related traumatic brain injury in U.S. military personnelChristine L Mac Donald, Ann M Johnson, Dana Cooper, et al.Abdominal Radiology (New York)|June 26, 2022
SAR user guide to the rectal MR synoptic report (primary staging)Z Kassam, R Lang, D D B Bates, et al.Cancer|July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis BW Ray Kim, Rohit Loomba, Thomas Berg, et al.Gastroenterology|December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis BScott Fung, Peter Kwan, Milotka Fabri, et al.Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.Plos One|May 13, 2021
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBVCalvin Q Pan, Ting-Tsung Chang, Si Hyun Bae, et al.Journal of Neurotrauma|May 21, 2016
Outcome Trends after US Military Concussive Traumatic Brain InjuryChristine L Mac Donald, Ann M Johnson, Linda Wierzechowski, et al.Lancet (London, England)|December 14, 2012
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyPatrick Marcellin, Edward Gane, Maria Buti, et al.Pageof 18